[1] TANG L,YIN T.Pharmaceutical analysis and care for antibiotic encephalopathy caused by cefoselis in uremic patients[J]. Chin J Clin Pharmacol(中国临床药理学杂志), 2016(17): 1614-1616. [2] WANG X, WANG YR, YAN N, et al.Piperacillin/tazobactam-induced antibiotic encephalopathy in a patient with chronic renal insufficiency[J]. Chinese Pharmacist(中国药师), 2018, 21(2): 311-312. [3] Sanford. Fever(热病)[M]. 48th ed. Beijing: Peking Union Medical College Press, 2019. [4] NARANJO CA, SHEAR NH, LANCTOT KL.Advances in the diagnosis of adverse drug reactions[J]. Journal of Clinical Pharmacology,1992, 32(10): 897-904. [5] MOU P, LIAO CB, XU SY, et al.Analysis of pharmacists using the Naranjo's evaluation scale to diagnose adverse drug reaction cases[J]. J Mod Med Health(现代医药卫生), 2018, 34(20): 3262-3264. [6] LAMOTH F, BUCLIN T, PASCUAL A, et al.High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function[J]. Antimicrobial Agents and Chemotherapy, 2010, 54(10): 4360-4367. [7] REN FY, LI YZ, ZHANG DS.One case of psychiatric symptoms caused by intravenous infusion of ceftriaxone sodium(fanshengshufu)[J]. Journal of Pharmaceutical Practice(药学实践杂志), 2006(1): 45. [8] LIU DL.A case of hallucinogenic psychosis caused by ceftriaxone sodium[J]. Chin J Geriatr(中华老年医学杂志), 2004, 23(6): 413. [9] ZHANG MX, HUANG J.Mental disorders during treatment with ceftriaxone/sulbactam injection[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2004, 6(3): 199-200. [10] FAN M.Literature analysis on the adverse reactions of cephalos-porins[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2012, 9(2): 119-123. [11] WANG GL.Clinical analysis of neuropsychiatric symptoms in patients with chronic renal failure caused by cephalosporin antibiotics[J]. China Clin Prac Med(中国临床实用医学), 2010, 4(1): 197-198. [12] ZHENG CZ, SHU YB, Li CP.Clinical analysis of cephalosporin encephalopathy in 28 patients with chronic renal failure[J]. Anhui Medical Journal(安徽医学), 2014(2): 149-151. [13] GRILL MF, MAGANTI RK.Neurotoxic effects associated with antibiotic use: management considerations[J]. British Journal of Clinical Pharmacology, 2011, 72(3): 381-393. [14] Endocrinology and Metabolism Branch of Chinese Association of Geriatric, Research Committee of Clinical Toxicology of Chinese Society of Toxicology. Expert consensus on risk management of polypharmacy in elderly[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(10): 55-68. [15] JIANG MH, XU YP, HAN ZW, et al.Risk factors for antibiotic encephalopathy in peritoneal dialysis patients[J]. Chinese Journal of Microcirculation(微循环学杂志), 2019, 29(1): 73-76. [16] REN Q.Clinical analysis of patients with antibiotic encephalopathy induced by cephalosporins[J]. Journal of China Prescription Drug(中国处方药), 2019, 17(7): 53-54. [17] CHEN TA, LIU X, LIANG Y.Analysis on characteristics of antibacterial use in inpatients with chronic kidney disease[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(9): 42-46. [18] ZHANG RK, DONG SX, ZHANG ZP.One case of mental disorder caused by ceftriaxone sodium in patient with renal insufficiency[J]. Mod Diagn Treat(现代诊断与治疗), 2014(9): 2133. |